Veru Inc. Common Stock VERU
i
Market datapartial · fetched 2026-11-10T22:25:19.973Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-13
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-10T21:00:00.58743859Z
FundamentalsAlpha Vantage · unavailable
Veru Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 1.50 | 799.7% | 52.8% | |||
| 25Δ | 1.69 | 789.5% | 44.0% | |||
| 30Δ | 1.87 | 779.0% | 35.2% | |||
| 35Δ | 2.03 | 749.4% | 28.0% | |||
| 40Δ | 2.11 | 681.3% | 24.3% | |||
| 45Δ | 2.19 | 613.3% | 20.6% | |||
| 50Δ | 2.65 | 731.6% | 43.5% | 2.28 | 545.2% | 16.8% |
| 55Δ | 2.39 | 679.0% | 32.5% | 2.36 | 477.1% | 13.1% |
| 60Δ | 2.19 | 638.6% | 25.0% | 2.44 | 409.0% | 9.4% |
| 65Δ | 1.99 | 597.9% | 17.7% | 2.63 | 370.8% | 6.5% |
| 70Δ | 1.88 | 552.9% | 14.4% | 3.03 | 396.8% | 5.6% |
| 75Δ | 1.78 | 508.0% | 11.0% | 3.43 | 422.7% | 4.6% |
| 80Δ | 1.67 | 463.0% | 7.7% | 3.84 | 448.7% | 3.7% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.50
- IV
- 799.7%
- B/E move
- 52.8%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.69
- IV
- 789.5%
- B/E move
- 44.0%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.87
- IV
- 779.0%
- B/E move
- 35.2%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.03
- IV
- 749.4%
- B/E move
- 28.0%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.11
- IV
- 681.3%
- B/E move
- 24.3%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.19
- IV
- 613.3%
- B/E move
- 20.6%
50Δ
- Pseudo strike
- 2.65
- IV
- 731.6%
- B/E move
- 43.5%
- Pseudo strike
- 2.28
- IV
- 545.2%
- B/E move
- 16.8%
55Δ
- Pseudo strike
- 2.39
- IV
- 679.0%
- B/E move
- 32.5%
- Pseudo strike
- 2.36
- IV
- 477.1%
- B/E move
- 13.1%
60Δ
- Pseudo strike
- 2.19
- IV
- 638.6%
- B/E move
- 25.0%
- Pseudo strike
- 2.44
- IV
- 409.0%
- B/E move
- 9.4%
65Δ
- Pseudo strike
- 1.99
- IV
- 597.9%
- B/E move
- 17.7%
- Pseudo strike
- 2.63
- IV
- 370.8%
- B/E move
- 6.5%
70Δ
- Pseudo strike
- 1.88
- IV
- 552.9%
- B/E move
- 14.4%
- Pseudo strike
- 3.03
- IV
- 396.8%
- B/E move
- 5.6%
75Δ
- Pseudo strike
- 1.78
- IV
- 508.0%
- B/E move
- 11.0%
- Pseudo strike
- 3.43
- IV
- 422.7%
- B/E move
- 4.6%
80Δ
- Pseudo strike
- 1.67
- IV
- 463.0%
- B/E move
- 7.7%
- Pseudo strike
- 3.84
- IV
- 448.7%
- B/E move
- 3.7%
Options history
Table
| Date | IV (%) |
|---|---|
| 224.47% | |
| 173.54% | |
| 196.62% | |
| 201.70% | |
| 220.89% | |
| 211.12% | |
| 294.73% | |
| 207.39% | |
| 224.35% | |
| 252.82% | |
| 223.60% | |
| 214.03% | |
| 255.13% | |
| 348.42% | |
| 279.25% |
Biotechnology
VIR
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San…
More →VKTX
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. The company is headquartered…
More →VNDA
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company is…
More →VOR
Vor Biopharma, Inc., an early stage cell therapy company, develops hematopoietic stem cell (eHSC) therapies designed for cancer patients. The company is headquartered in…
More →VRDN
Description unavailable
More →VRTX
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
More →